Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Trial to Detect Liver Cancer Through Quantification of cfDNA Methylation in Blood Samples: A LAM Insight Trial Study

NCT03694600 is registered in ClinicalTrials.gov with Helio Genomics as lead sponsor.

NCT NCT03694600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03694600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Trial to Detect Liver Cancer Through Quantification of cfDNA Methylation in Blood Samples: A LAM Insight Trial Study
Lead sponsor
Helio Genomics
Phase
Observational
Overall status
Active, not recruiting
Start date
February 4, 2019
Completion date
December 30, 2027
Enrollment
1,900 (estimated)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis